The DOI matches its Crossref record; 213 of the 215 references it cites were found in a registry or an index.
Kynurenines in the mammalian brain: when physiology meets pathology
Open accessAbstract
The essential amino acid tryptophan is not only a precursor of serotonin but is also degraded to several other neuroactive compounds, including kynurenic acid, 3-hydroxykynurenine and quinolinic acid. The synthesis of these metabolites is regulated by an enzymatic cascade, known as the kynurenine pathway, that is tightly controlled by the immune system. Dysregulation of this pathway, resulting in hyper-or hypofunction of active metabolites, is associated with neurodegenerative and other neurological disorders, as well as with psychiatric diseases such as depression and schizophrenia. With recently developed pharmacological agents, it is now possible to restore metabolic equilibrium and envisage novel therapeutic interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Kynurenine and its metabolites, including kynurenic acid and quinolinic acid, have been implicated in mental health (Cervenka et al., 2017;Schwarcz et al., 2012).”
From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Schwarcz et al., 2012
In the citing paper
“Mounting evidence suggests that the GM modulates the tryptophan and kynurenine pathways and is a humoral route through which the GM may influence cognition at the level of the CNS (206–210).”
From Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis (2023) · cites this paper as [209]
In the citing paper
“Other metabolites of tryptophan metabolism, kynurenines, have also been implicated in a range of neurobiological functions (392).”
From Diet and the Microbiota–Gut–Brain Axis: Sowing the Seeds of Good Mental Health (2021) · cites this paper as [392]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Ido expression by dendritic cells: tolerance and tryptophan catabolism
Mellor, A. L., & Munn, D. H. (2004) · Nature Reviews Immunology · doi:10.1038/nri1457 · Cited by 2,341
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Opitz, C. A., Litzenburger, U. M., Sahm, F., Ott, M., Tritschler, I., Trump, S., Schumacher, T., Jestaedt, L., Schrenk, D., Weller, M., et al. (2011) · Nature · doi:10.1038/nature10491 · Cited by 1,898
Mammalian nicotinic acetylcholine receptors: from structure to function
Albuquerque, E. X., Pereira, E. F. R., Alkondon, M., & Rogers, S. W. (2009) · Physiological Reviews · doi:10.1152/physrev.00015.2008 · Cited by 1,724
Blockade of N -Methyl-D-Aspartate Receptors May Protect Against Ischemic Damage in the Brain
Simon, R. P., Swan, J. H., Griffiths, T., & Meldrum, B. S. (1984) · Science · doi:10.1126/science.6093256 · Cited by 1,682
Microglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543
Anis, N. A., Berry, S. C., Burton, N. R., & Lodge, D. (1983) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1983.tb11031.x · Cited by 1,399
Quinolinic Acid: An Endogenous Metabolite That Produces Axon-Sparing Lesions in Rat Brain
Schwarcz, R. M., Whetsell, W. O., & Mangano, R. M. (1983) · Science · doi:10.1126/science.6849138 · Cited by 1,269
Self-citationLesion of striatal neurons with kainic acid provides a model for Huntington's chorea
Coyle, J. T., & Schwarcz, R. M. (1976) · Nature · doi:10.1038/263244a0 · Cited by 1,255
Self-citationSubanesthetic Doses of Ketamine Stimulate Psychosis in Schizophrenia
Lahti, A., Koffel, B., Laporte, D., & Tamminga, C. (1995) · Neuropsychopharmacology · doi:10.1016/0893-133x(94)00131-i · Cited by 965
Flagged first, then by citations
2 of the 215 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 1,002
Woodling, N. S., Colas, D., Wang, Q., Minhas, P. S., Panchal, M., Liang, X., Mhatre, S. D., Brown, H. D., Ko, N., Zagol-Ikapitte, I. A., et al. (2016) · Brain · doi:10.1093/brain/aww117 · Cited by 111
Formentini, L., Pereira, M. P., Sánchez-Cenizo, L., Santacatterina, F., Lucas, J. J., Fernández-Balbuena, C. N., Martı́nez-Serrano, A., & Cuezva, J. M. (2014) · The EMBO Journal · doi:10.1002/embj.201386392 · Cited by 111
Zádori, D., Veres, G., Szalárdy, L., Klivènyi, P., & Vécsei, L. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170929 · Cited by 108
Sun, P., Wang, M., Liu, Y., Li, L., Chai, X., Zheng, W., Chen, S., Zhu, X., & Zhao, S. (2023) · Microbiome · doi:10.1186/s40168-023-01606-x · Cited by 112
Kynurenic Acid in the Digestive System–-New Facts, New Challenges
Turski, M. P., Turska, M., Paluszkiewicz, P., Parada-Turska, J., & Oxenkrug, G. F. (2013) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s12536 · Cited by 102
Schwieler, L., Samuelsson, M., Frye, M. A., Bhat, M., Schuppe‐Koistinen, I., Jungholm, O., Johansson, A. G. M., Landén, M., Sellgren, C. M., & Erhardt, S. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0517-7 · Cited by 107
Wang, B., Lian, Y., Su, W., Wei, P., Dong, X. W., Liu, L.-L., Gong, H., Zhang, T., Jiang, C., & Wang, Y. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.11.017 · Cited by 105
Nay, K., Smiles, W. J., Kaiser, J., McAloon, L. M., Loh, K., Galić, S., Oakhill, J. S., Gundlach, A. L., & Scott, J. W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084052 · Cited by 112
Zheng, X., An, K., Dai, C., Liang, Y. L., Xie, T., Xie, L. Y., Peng, Y., Wang, G., & Hao, H. (2012) · Analytical Chemistry · doi:10.1021/ac3025202 · Cited by 105
Early exposure to antibiotic drugs and risk for psychiatric disorders: a population-based study
Lavebratt, C., Yang, L. L., Giacobini, M., Forsell, Y., Schalling, M., Partonen, T., & Gissler, M. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0653-9 · Cited by 107
Feng, X., Jia, M., Cai, M., Zhu, T., Hashimoto, K., & Yang, J. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03085-y · Cited by 125
Altered kynurenine pathway metabolites in serum of chronic migraine patients
Curto, M., Lionetto, L., Negro, A., Capi, M., Fazio, F., Giamberardino, M. A., Simmaco, M., Nicoletti, F., & Martelletti, P. (2016) · The Journal of Headache and Pain · doi:10.1186/s10194-016-0638-5 · Cited by 104
Acute tryptophan depletion in humans: a review of theoretical, practical and ethical aspects
Young, S. N. (2013) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.120209 · Cited by 110
Regulating the balance between the kynurenine and serotonin pathways of tryptophan metabolism
Li, Y., Hu, N., Yang, D., Oxenkrug, G. F., & Yang, Q. (2017) · FEBS Journal · doi:10.1111/febs.14026 · Cited by 101
Tryptophan metabolites in depression: Modulation by gut microbiota
Lukić, I., Ivković, S., Mitić, M., & Adžić, M. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.987697 · Cited by 113
Justinová, Z., Mascia, P., Wu, H., Secci, M. E., Redhi, G. H., Panlilio, L. V., Scherma, M., Barnes, C., Parashos, A., Zara, T., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3540 · Cited by 99
Self-citationPlitman, E., de la Fuente‐Sandoval, C., Reyes-Madrigal, F., Chavez, S., Gómez-Cruz, G., León-Ortíz, P., & Graff‐Guerrero, A. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv118 · Cited by 99
Bartoli, F., Misiak, B., Callovini, T., Cavaleri, D., Cioni, R. M., Crocamo, C., Savitz, J. B., & Carrà, G. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00913-1 · Cited by 105
Going with the grain: Fiber, cognition, and the microbiota-gut-brain-axis
Berding, K., Carbia, C., & Cryan, J. F. (2021) · Experimental Biology and Medicine · doi:10.1177/1535370221995785 · Cited by 100
Time and space profiling of NMDA receptor co‐agonist functions
Mothet, J., Bail, M. L., & Billard, J. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13204 · Cited by 103
Leclercq, S., Schwarz, M., Delzenne, N. M., Stärkel, P., & de Timary, P. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01610-5 · Cited by 102
Cytokines and tryptophan metabolites can predict depressive symptoms in pregnancy
Sha, Q., Madaj, Z. B., Keaton, S. A., Galvis, M. L. E., Smart, L., Krzyżanowski, S., Fazleabas, A. T., Leach, R. E., Postolache, T. T., Achtyes, E. D., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01801-8 · Cited by 101
Strasser, B., Becker, K., Fuchs, D., & Gostner, J. M. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.02.030 · Cited by 97
Messaoud, A., Mensi, R., Douki, W., Neffati, F., Najjar, M. F., Gobbi, G., Valtorta, F., Gaha, L., & Comai, S. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2018.1468031 · Cited by 100
Kynurenine Pathway in Diabetes Mellitus—Novel Pharmacological Target?
Kozieł, K., & Urbańska, E. M. (2023) · Cells · doi:10.3390/cells12030460 · Cited by 104
Ben‐Azu, B., Aderibigbe, A. O., Ajayi, A. M., Eneni, A.-E. O., Omogbiya, I. A., Owoeye, O., Umukoro, S., & Iwalewa, E. O. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.02.052 · Cited by 97
Chen, W.-C., Chang, L.-H., Huang, S.-S., Huang, Y., Chih, C.-L., Kuo, H., Lee, Y., & Lee, I. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1572-7 · Cited by 101
How does the skeletal muscle communicate with the brain in health and disease?
Isaac, A. R., Lima‐Filho, R. A. S., & Lourenco, M. V. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108744 · Cited by 99
Kynurenine-3-monooxygenase: a review of structure, mechanism, and inhibitors
Smith, J. R., Jamie, J. F., & Guillemin, G. J. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.11.001 · Cited by 97
Role of Kynurenine Metabolism Pathway Activation in Major Depressive Disorders
Savitz, J. B. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_12 · Cited by 98
Clark, S. M., Pocivavsek, A., Nicholson, J. D., Notarangelo, F. M., LANGENBERG, P. W., McMahon, R. P., Kleinman, J. E., Hyde, T. M., Stiller, J. W., Postolache, T. T., et al. (2016) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.150226 · Cited by 94
Self-citationElevated kynurenine pathway metabolism during neurodevelopment: Implications for brain and behavior
Notarangelo, F. M., & Pocivavsek, A. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.03.001 · Cited by 97
Fazio, F., Lionetto, L., Curto, M., Iacovelli, L., Copeland, C. S., Neale, S. A., Bruno, V., Battaglia, G., Salt, T. E., & Nicoletti, F. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.06.020 · Cited by 94
Bain, K. A., McDonald, E., Moffat, F., Tutino, M., Castelino, M., Barton, A. C., Cavanagh, J., Ijaz, U. Z., Siebert, S., McInnes, I. B., et al. (2019) · British Journal of Dermatology · doi:10.1111/bjd.18008 · Cited by 98
Kynurenines link chronic inflammation to functional decline and physical frailty
Westbrook, R., Chung, T., Lovett, J., Ward, C. W., Joca, H. C., Yang, H., Khadeer, M., Tian, J., Xue, Q., Le, A., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.136091 · Cited by 92
Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing- Remitting Multiple Sclerosis
Mancuso, R., Hernis, A., Agostini, S., Rovaris, M., Caputo, D., Fuchs, D., & Clerici, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130715 · Cited by 94
Serum kynurenic acid is reduced in affective psychosis
Wurfel, B. E., Drevets, W. C., Bliss, S. A., McMillin, J. R., Suzuki, H., Ford, B. N., Morris, H. M., Teague, T. K., Dantzer, R., & Savitz, J. B. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.88 · Cited by 91
Volatility as a Concept to Understand the Impact of Stress on the Microbiome
Bastiaanssen, T. F. S., Gururajan, A., van de Wouw, M., Moloney, G. M., Ritz, N. L., Long-Smith, C. M., Wiley, N., Murphy, A., Lyte, J. M., Fouhy, F., et al. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.105047 · Cited by 93
Wang, X., Li, Y., Wu, L., Xiao, S., Ji, Y., Tan, Y., Jiang, C., & Zhang, G. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111065 · Cited by 95
Kim, S., Miller, B. J., Stefanek, M. E., & Miller, A. H. (2015) · Cancer · doi:10.1002/cncr.29302 · Cited by 93
Xie, W., Cai, L., Yu, Y., Gao, L., Xiao, L., He, Q., Zhijun, R., & Liu, Y. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-41 · Cited by 91
Grandjean, J., Azzinnari, D., Seuwen, A., Sigrist, H., Seifritz, E., Pryce, C. R., & Rudin, M. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.08.013 · Cited by 98
Notarangelo, F. M., Wilson, E. H., Horning, K. J., Thomas, M. A. R., Harris, T. H., Fang, Q., Hunter, C. A., & Schwarcz, R. M. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.11.011 · Cited by 91
Self-citationYılmaz, C., Özdemir, F., & Gökmen, V. (2019) · LWT · doi:10.1016/j.lwt.2019.108655 · Cited by 91
Meynier, M., Baudu, E., Rolhion, N., Defaye, M., Straube, M., Daugey, V., Modoux, M., Wawrzyniak, I., Delbac, F., Villéger, R., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2021.2022997 · Cited by 90
Chiappelli, J., Pocivavsek, A., Nugent, K. L., Notarangelo, F. M., Kochunov, P., Rowland, L. M., Schwarcz, R. M., & Hong, L. E. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.243 · Cited by 92
Self-citationPershing, M. L., Bortz, D. M., Pocivavsek, A., Fredericks, P. J., Jørgensen, C. V., Vunck, S. A., Leuner, B., Schwarcz, R. M., & Bruno, J. P. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.017 · Cited by 92
Self-citationMoffett, J. R., Arun, P., Puthillathu, N., Vengilote, R., Ives, J. A., Badawy, A. A.-B., & Namboodiri, A. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00031 · Cited by 89
“Yet, the precise nature of the benefits that the kynurenine pathway confers on fitness is a matter of ongoing debate (7, 9, 16, 22, 23).”
BackgroundGlutaminase in microglia: A novel regulator of neuroinflammation
Ding, L., Xu, X., Li, C., Wang, Y., Xia, X., & Zheng, J. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.11.038 · Cited by 91
The Role of Inflammation in Brain Cancer
Sowers, J. L., Johnson, K. M., Conrad, C. C., Patterson, J. T., & Sowers, L. C. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-0348-0837-8_4 · Cited by 93
Young, K. D., Drevets, W. C., Dantzer, R., Teague, T. K., Bodurka, J., & Savitz, J. B. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.04.007 · Cited by 91
García-Aguilar, A., & Cuezva, J. M. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01322 · Cited by 89
The microbiota-gut-brain axis: Focus on the fundamental communication pathways
Bistoletti, M., Bosi, A., Banfi, D., Giaroni, C., & Baj, A. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.08.012 · Cited by 91
Targeting metabolic pathways for extension of lifespan and healthspan across multiple species
Parkhitko, A. A., Filine, E., Mohr, S. E., Moskalev, A., & Perrimon, N. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101188 · Cited by 91
Evans, A. K., Strassmann, P. S., Lee, I.-P., & Sapolsky, R. M. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.11.012 · Cited by 87
Genetic and biochemical changes of the serotonergic system in migraine pathobiology
Gasparini, C., Smith, R. A., & Griffiths, L. R. (2017) · The Journal of Headache and Pain · doi:10.1186/s10194-016-0711-0 · Cited by 91
Gestational Factors throughout Fetal Neurodevelopment: The Serotonin Link
Hanswijk, S. I., Spoelder, M., Shan, L., Verheij, M. M. M., Muilwijk, O. G., Li, W., Liu, C., Kolk, S. M., & Homberg, J. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165850 · Cited by 86
Gut microbiota, kynurenine pathway and mental disorders – Review
Więdłocha, M., Marcinowicz, P., Janoska-Jaździk, M., & Szulc, A. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110145 · Cited by 90
Pocivavsek, A., Thomas, M. A. R., Elmer, G. I., Bruno, J. P., & Schwarcz, R. M. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3452-2 · Cited by 90
Self-citationRecent advances in clinical trials targeting the kynurenine pathway
Pires, A. S., Sundaram, G., Heng, B., Krishnamurthy, S., Brew, B. J., & Guillemin, G. J. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108055 · Cited by 86
Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosis
Georgin‐Lavialle, S., Moura, D. S., Salvador, A., Chauvet‐Gélinier, J., Launay, J., Damaj, G. L., Côté, F., Soucie, E. L., Chandesris, M., Barète, S., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.216 · Cited by 90
Cytokine alterations in panic disorder: A systematic review
Quagliato, L. A., & Nardi, A. E. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.11.094 · Cited by 89
Almulla, A. F., Vasupanrajit, A., Tunvirachaisakul, C., Al‐Hakeim, H. K., Solmi, M., Verkerk, R. M., & Maes, M. H. J. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01552-4 · Cited by 78
Rossetti, A. C., Papp, M., Gruca, P., Paladini, M. S., Racagni, G., Riva, M. A., & Molteni, R. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.10.022 · Cited by 90
Tryptophan Metabolism and White Matter Integrity in Schizophrenia
Chiappelli, J., Postolache, T. T., Kochunov, P., Rowland, L. M., Wijtenburg, S. A., Shukla, D. K., Tagamets, M. A., Du, X. M., Savransky, A., Lowry, C. A., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.66 · Cited by 84
Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder
Birner, A., Platzer, M., Bengesser, S., Dalkner, N., Fellendorf, F., Queissner, R., Pilz, R., Rauch, P., Maget, A., Hamm, C., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172699 · Cited by 80
Neurophysiological Changes Induced by Chronic Toxoplasma gondii Infection
Tedford, E., & McConkey, G. A. (2017) · Pathogens · doi:10.3390/pathogens6020019 · Cited by 83
Joyce, M. K. P., Uchendu, S., & Arnsten, A. F. T. (2024) · Biological Psychiatry · doi:10.1016/j.biopsych.2024.06.016 · Cited by 86
Schwarcz, R. M. (2016) · Advances in pharmacology · doi:10.1016/bs.apha.2016.01.005 · Cited by 85
Self-citationKynurenic Acid Levels are Increased in the CSF of Alzheimer’s Disease Patients
González-Sánchez, M., Jiménez, J., Narváez, A., Antequera, D., Llamas-Velasco, S., Martín, A. H.-S., Molina Arjona, J. A., López de Munain, A., Lleó Bisa, A., Marco, M.-P., et al. (2020) · Biomolecules · doi:10.3390/biom10040571 · Cited by 84
Suzuki, H., Yamashiro, D., Ogawa, S., Kobayashi, M., Cho, D., Iizuka, A., Tsukamoto‐Yasui, M., Takada, M., Isokawa, M., Nagao, K., et al. (2020) · Frontiers in Nutrition · doi:10.3389/fnut.2020.586166 · Cited by 81
Jin, H., Zhang, Y., You, H., Tao, X., Wang, C., Jin, G., Wang, N., Ruan, H., Gu, D., Huo, X., et al. (2015) · Scientific Reports · doi:10.1038/srep10466 · Cited by 81
Kynurenic Acid Is a Nutritional Cue that Enables Behavioral Plasticity
Lemieux, G. A., Cunningham, K. A., Lin, L., Mayer, F., Werb, Z., & Ashrafi, K. (2015) · Cell · doi:10.1016/j.cell.2014.12.028 · Cited by 80
Rudzki, L., & Szulc, A. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00205 · Cited by 80
Larkin, P. B., Sathyasaikumar, K. V., Notarangelo, F. M., Funakoshi, H., Nakamura, T., Schwarcz, R. M., & Muchowski, P. J. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.07.002 · Cited by 82
Self-citationLiu, D., Ray, B., Neavin, D. R., Zhang, J., Athreya, A. P., Biernacka, J. M., Bobo, W. V., Hall‐Flavin, D. K., Skime, M. K., Zhu, H., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-017-0056-8 · Cited by 80
Immune system and glucose metabolism interaction in schizophrenia: A chicken–egg dilemma
Steiner, J. H., Bernstein, H., Schiltz, K., Müller, U., Westphal, S., Drexhage, H. A., & Bogerts, B. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.09.016 · Cited by 81
Skaggs, K., Goldman, D. J., & Parent, J. M. (2014) · Glia · doi:10.1002/glia.22726 · Cited by 81
Dhakar, N. K., Caldera, F., Bessone, F., Cecone, C., Pedrazzo, A. R., Cavalli, R., Dianzani, C., & Trotta, F. (2019) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2019.115168 · Cited by 82
Diabesity and mood disorders: Multiple links through the microbiota-gut-brain axis
Farzi, A., Hassan, A. M., Zenz, G., & Holzer, P. D. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.11.003 · Cited by 83
Wu, H., Okuyama, M., Kajii, Y., Pocivavsek, A., Bruno, J. P., & Schwarcz, R. M. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt157 · Cited by 78
Self-citationManchia, M., Carpiniello, B., Valtorta, F., & Comai, S. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00427 · Cited by 80
Cao, B., Chen, Y., Ren, Z., Pan, Z., McIntyre, R. S., & Wang, D. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.01.018 · Cited by 76
Sun, P., Wang, M., Li, Z., Wei, J., Liu, F., Zheng, W., Zhu, X., Chai, X., & Zhao, S. (2022) · Theranostics · doi:10.7150/thno.72756 · Cited by 78
Inflammation in the pathogenesis of depression: a disorder of neuroimmune origin
Corrigan, M., O’Rourke, A. M., Moran, B., Fletcher, J. M., & Harkin, A. (2023) · Neuronal Signaling · doi:10.1042/ns20220054 · Cited by 81
Palmini, R. B., Masi, A., Narducci, R., Cavone, L., Maratea, D., Cozzi, A., Sili, M., Moroni, F., & Mannaioni, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082180 · Cited by 77
Barros-Santos, T., Silva, K. S. O., Libarino-Santos, M., Cata-Preta, E. G., Reis, H. S., Tamura, E. K., de Oliveira-Lima, A. J., Berro, L. F., Uetanabaro, A. P. T., & Marinho, E. A. V. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234037 · Cited by 76
Effect of combined chronic predictable and unpredictable stress on depression-like symptoms in mice
Qiao, Y., Zhao, J., Li, C., Zhang, M., Wei, L., Zhang, X., Kurskaia, O. V., Bi, H., & Gao, T. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-5168 · Cited by 80
Sarno, E., Moeser, A. J., & Robison, A. J. (2021) · Advances in pharmacology · doi:10.1016/bs.apha.2021.03.004 · Cited by 84
Cooper, A. J. L., & Kuhara, T. (2013) · Metabolic Brain Disease · doi:10.1007/s11011-013-9444-9 · Cited by 75
Sleep disturbance and kynurenine metabolism in depression
Cho, H. J., Savitz, J. B., Dantzer, R., Teague, T. K., Drevets, W. C., & Irwin, M. R. (2017) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.05.016 · Cited by 78
Maternal High-fat Diet Programs Offspring Emotional Behavior in Adulthood
Winther, G., Elfving, B., Müller, H. K., Lund, S. A., & Wegener, G. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.07.014 · Cited by 75
Yang, D., Zhang, S., Fang, X., Guo, L., Hu, N., Zhanling, G., Li, X., Yang, S., He, J. C., Kuang, C., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01079 · Cited by 75
The tryptophan metabolic pathway of the microbiome and host cells in health and disease
Miyamoto, K., Sujino, T., & Kanai∥, T. (2024) · International Immunology · doi:10.1093/intimm/dxae035 · Cited by 85
Swardfager, W., Hennebelle, M., Yu, D., Hammock, B. D., LEVITT, A. J., Hashimoto, K., & Taha, A. Y. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.01.010 · Cited by 78
Bergamini, G., Mechtersheimer, J., Azzinnari, D., Sigrist, H., Buerge, M., Dallmann, R., Freije, R., Kouraki, A., Opacka‐Juffry, J., Seifritz, E., et al. (2018) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.01.004 · Cited by 77
IDO and TDO as a potential therapeutic target in different types of depression
Qin, Y., Wang, N., Zhang, X., Han, X., Zhai, X., & Lu, Y. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0290-7 · Cited by 79
Glutamatergic Dysfunctioning in Alzheimer's Disease and Related Therapeutic Targets
Zádori, D., Veres, G., Szalárdy, L., Klivènyi, P., Toldi, J., & Vécsei, L. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132621 · Cited by 76
Lefèvre, A., Mavel, S., Nadal‐Desbarats, L., Galineau, L., Attucci, S., Dufour, D. F., Sokol, H., & Emond, P. (2018) · Talanta · doi:10.1016/j.talanta.2018.11.094 · Cited by 74
Fleiss, B., Wong, F. Y., Brownfoot, F., Shearer, I. K., Baud, O., Walker, D. W., Gressèns, P., & Tolcos, M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00188 · Cited by 79
Metadata
- Authors
- Schwarcz, R., Bruno, J. P., Muchowski, P. J., & Wu, H.-Q.
- Affiliations
- University of Maryland, Baltimore (US)
- The Ohio State University (US)
- University of California, San Francisco (US)
- Corresponding author
- Schwarcz, Robert
- Venue
- Nature Reviews Neuroscience
- Published
- 2012-06-08
- Volume
- 13
- Issue
- 7
- Pages
- 465-477
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- PMC
- PMC3681811
- OpenAlex
- W2060050678
- Cited by
- 1,530
- References
- 215
- Citations by year
- 2026: 157 · 2025: 137 · 2024: 124 · 2023: 98 · 2022: 118 · 2021: 145 · 2020: 132 · 2019: 95 · 2018: 83 · 2017: 96 · 2016: 98 · 2015: 105 · 2014: 64 · 2013: 63 · 2012: 13
- FWCI
- 5.11
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (R01MH083729)
- National Institute of Neurological Disorders and Stroke (R01NS057715)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- kynurenine pathway, tryptophan metabolism, kynurenic acid, 3-hydroxykynurenine, quinolinic acid, neuroactive metabolites, neurodegenerative diseases, depression, schizophrenia, therapeutic targeting
- MeSH terms
- Animals, Brain, Humans, Kynurenine, Nervous System Diseases, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review